SCHEMBL31365145

SCHEMBL31365145

COC(=O)c1ncnc(O)c1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.45
KDM4C Q9H3R0 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.38
KDM4E B2RXH2 6/20 0.37
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
POLB P06746 2/20 0.36
RAB9A P51151 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA12 O43570 3/20 0.35
CA1 P00915 3/20 0.35
CA2 P00918 3/20 0.35
CA7 P43166 3/20 0.35
CA9 Q16790 3/20 0.35
CA14 Q9ULX7 3/20 0.35
LMNA P02545 2/20 0.34
GAA P10253 1/20 0.34
NFKB1 P19838 1/20 0.34
XDH P47989 1/20 0.34
GFER P55789 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18743114 1.00 NPSR1 (0.45) NPSR1KDM4CL3MBTL1KDM4EALDH1A1
SCHEMBL8201600 0.83 NPSR1 (0.43) NPSR1KDM4CL3MBTL1KDM4EALDH1A1
SCHEMBL14074710 0.83 NPSR1 (0.43) NPSR1KDM4CL3MBTL1KDM4EALDH1A1
SCHEMBL8201059 0.83 NPSR1 (0.43) NPSR1KDM4CL3MBTL1KDM4EALDH1A1
SCHEMBL1150519 0.82 NPSR1 (0.46) NPSR1KDM4CL3MBTL1KDM4EPOLB
SCHEMBL31032919 0.81 NPSR1 (0.42) NPSR1KDM4CL3MBTL1KDM4EALDH1A1
SCHEMBL28379725 0.81 NPSR1 (0.42) NPSR1KDM4CL3MBTL1KDM4EALDH1A1
SCHEMBL22119946 0.81 NPSR1 (0.42) NPSR1KDM4CL3MBTL1KDM4EALDH1A1
SCHEMBL18703831 0.80 NPC1 (0.43) NPSR1KDM4EALDH1A1SMN1; SMN2RAB9A
SCHEMBL13162110 0.75 NPSR1 (0.36) NPSR1KDM4CL3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114026081-B Pyridone derivatives as selective cytotoxic agents against HIV-infected cells 默沙东有限责任公司 2025-02-11 CN disclosed